These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1978336)

  • 1. Modulation of expression of the hepatitis B virus surface antigen gene by the viral X-gene product.
    Rossner MT; Jackson RJ; Murray K
    Proc Biol Sci; 1990 Jul; 241(1300):51-8. PubMed ID: 1978336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. trans-activation of viral enhancers by the hepatitis B virus X protein.
    Spandau DF; Lee CH
    J Virol; 1988 Feb; 62(2):427-34. PubMed ID: 2826805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication.
    Nakatake H; Chisaka O; Yamamoto S; Matsubara K; Koshy R
    Virology; 1993 Aug; 195(2):305-14. PubMed ID: 8337816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
    Oguey D; Dumenco LL; Pierce RH; Fausto N
    Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-complementation among naturally occurring deletion mutants of hepatitis B virus and integrated viral DNA for the production of viral particles with mutant genomes in hepatoma cell lines.
    Okamoto H; Wang Y; Tanaka T; Machida A; Miyakawa Y; Mayumi M
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():407-14. PubMed ID: 8383176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity.
    Kim H; Lee SA; Won YS; Lee H; Kim BJ
    World J Gastroenterol; 2015 Feb; 21(6):1794-803. PubMed ID: 25684944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
    Wu L; He JW; Yao X; Li HM; Wen YM
    J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transcriptional control of the level of mRNA by hepatitis B virus X gene in the transient expression system using human hepatic cells.
    Shimazu T; Takada S; Ueno Y; Hayashi Y; Koike K
    Genes Cells; 1998 Jul; 3(7):477-84. PubMed ID: 9753428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection.
    Gong ZJ; De Meyer S; van Pelt J; Hertogs K; Depla E; Soumillion A; Fevery J; Yap SH
    Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells.
    Crowley CW; Liu CC; Levinson AD
    Mol Cell Biol; 1983 Jan; 3(1):44-55. PubMed ID: 6298607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
    Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antigenicity of major hydrophilic region II of hepatitis B virus surface antigen].
    Tian YJ; Zhang ZM; Xia C; Liu SP; Yu Y; Huang HP; Yang Y; Lu MJ; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):92-7. PubMed ID: 17362631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of the hepatitis B virus surface antigen containing pre-S2 protein in mouse cells using a bovine papillomavirus vector.
    Yoneyama T; Akatsuka T; Miyamura T
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1931-9. PubMed ID: 2841407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic potential of hepatitis B virus.
    Koike K; Shirakata Y; Yaginuma K; Arii M; Takada S; Nakamura I; Hayashi Y; Kawada M; Kobayashi M
    Mol Biol Med; 1989 Apr; 6(2):151-60. PubMed ID: 2615644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic transformation of somatic cells. XIV. Expression of gene coding for the human hepatitis B virus surface antigen in mammalian cells].
    Aprelikova ON; Mikhaĭlov VM; Tomilin NV; Bychko VV; Pumpen PP
    Tsitologiia; 1987 Apr; 29(4):484-9. PubMed ID: 3603707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of the hepatitis B virus surface antigen gene by rat hepatocyte X mouse hepatoma hybrid cells].
    Houssais JF; Chenciner N; Malpièce Y; Zilberfarb D
    C R Acad Sci III; 1986; 303(17):693-8. PubMed ID: 3101983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of whole-genome lamivudine-resistant hepatitis B virus mutant and its replication and expression in HepG2 cells].
    Sun J; Wang C; Wen SJ; Wang ZH; Hou JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):991-3. PubMed ID: 17666334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effects of destruxin B on hepatitis B virus surface antigen gene expression in human hepatoma cells.
    Chen HC; Chou CK; Sun CM; Yeh SF
    Antiviral Res; 1997 May; 34(3):137-44. PubMed ID: 9191021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient.
    Jeantet D; Chemin I; Mandrand B; Zoulim F; Trepo C; Kay A
    Hepatology; 2002 May; 35(5):1215-24. PubMed ID: 11981772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of HBx mRNA in HepG2.2.15 cells by small interfering RNA.
    Jiao J; Cao H; Chen XW; Zhou MJ; Liu ZH; Ding ZH
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1114-8. PubMed ID: 17998838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.